Deals

Qingfeng Pharmaceutical Signs Five‑Year Strategic Collaboration with China Association Against Epilepsy – Advancing Discipline Development, Talent Cultivation and Patient Assistance
Qingfeng Pharmaceutical

Qingfeng Pharmaceutical Signs Five‑Year Strategic Collaboration with China Association Against Epilepsy – Advancing Discipline Development, Talent Cultivation and Patient Assistance

Qingfeng Pharmaceutical Group and the China Association Against Epilepsy (CAAE) officially signed a strategic collaboration agreement, committing to a five‑year partnership spanning discipline development, talent cultivation and public welfare assistance.…

Biohaven Licenses MoDE Pan‑IgG Degrader Portfolio to Ono Pharmaceutical in Asia – Up to USD 100 Million in Near‑Term Payments for BHV‑1300 Franchise

Biohaven Licenses MoDE Pan‑IgG Degrader Portfolio to Ono Pharmaceutical in Asia – Up to USD 100 Million in Near‑Term Payments for BHV‑1300 Franchise

Mirxes Partners with Thailand's National Cancer Institute on Blood‑Based Colorectal Cancer Screening – 2,000‑Subject Prospective Triage Study Backs "Cancer Moonshot 2056"

Mirxes Partners with Thailand’s National Cancer Institute on Blood‑Based Colorectal Cancer Screening – 2,000‑Subject Prospective Triage Study Backs “Cancer Moonshot 2056”

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
CSPC Pharmaceutical in Advanced Talks for $5B Licensing Deals
ADC / XDCCSPC Pharmaceutical

CSPC Pharmaceutical in Advanced Talks for $5B Licensing Deals

Astellas Pharma Licenses Evopoint's CLDN18.2 ADC for Global Development
ADC / XDCAstellas Pharma

Astellas Pharma Licenses Evopoint’s CLDN18.2 ADC for Global Development

Danaher Partners with AstraZeneca to Advance Precision Medicine
AIAstraZeneca

Danaher Partners with AstraZeneca to Advance Precision Medicine

Ganzhou Hemay Pharma Files for HK IPO with SDIC Securities Sponsorship
CancerHemay Pharmaceutical

Ganzhou Hemay Pharma Files for HK IPO with SDIC Securities Sponsorship

Show More